Press-release for stocks related to treatment for astrazeneca plc

tags : Treatment entities : Astrazeneca plc

save search

FASENRA approved for treatment of children aged 6 to 11 with severe asthma
Published: 2024-04-11 (Crawled : 12:00) - biospace.com/
AZNCF | News | $140.3 1.13% -4.19% 0

Health Technology

| 2.97% | O: 1.47% H: 1.16% C: -1.27%
AZN | News | $70.85 1.03% 1.02% 490K

Health Technology

| 4.78% | O: 3.34% H: 0.27% C: -0.62%
children approved treatment for

Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion in Listeria Monocytogenes Treatment Sector Predicted Amid Rising Foodborne Disease Incidence
Published: 2024-02-14 (Crawled : 00:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 0

Health Technology

| -6.95% | O: -2.14% H: 0.0% C: -0.63%
SNYNF | News | $94.25 1.67% -2.18% 0

Health Technology

| 1.37% | O: -2.71% H: 0.0% C: 0.0%
AZNCF | News | $140.3 1.13% -4.19% 0

Health Technology

| 13.6% | O: 0.87% H: 0.21% C: -2.23%
GSK | News | $41.24 1.6% 0.0% 1.6K

Health Technology

| -0.36% | O: 0.89% H: 0.41% C: 0.1%
LLY | News | $745.69 1.96% 0.04% 4K

Health Technology

| -0.53% | O: 0.38% H: 2.44% C: 1.54%
VRTX | $404.91 1.25% 1.43% 1.8K

Health Technology

| -2.68% | O: 0.56% H: 0.49% C: -0.12%
SNY | News | $47.69 1.15% 1.13% 1.1K

Health Technology

| 1.93% | O: -1.1% H: 0.0% C: 0.0%
BIIB | $193.18 -0.48% 5.8% 1.2M

Health Technology

| -14.77% | O: 0.16% H: 0.43% C: -2.76%
AZN | News | $70.85 1.03% 1.02% 490K

Health Technology

| 16.09% | O: 0.28% H: 0.93% C: 0.75%
AMGN | News | $273.54 0.6% 0.65% 8.5K

Health Technology

| -5.83% | O: -0.21% H: 0.34% C: 0.07%
disease report treatment expansion global infections market

Global Epidural Abscess Treatment Market Report 2024 - Treatment Advances and Digital Health Technologies Shaping the Future of Epidural Abscess Care
Published: 2024-02-12 (Crawled : 15:30) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 0

Health Technology

| 13.6% | O: -0.57% H: 0.04% C: -1.74%
NVS | News | $97.28 2.27% 1.47% 190K

Health Technology

| -2.15% | O: -1.46% H: 1.04% C: 0.97%
LLY | News | $745.69 1.96% 0.04% 4K

Health Technology

| -0.15% | O: 0.09% H: 0.0% C: -0.48%
BMY | $48.72 -0.55% 250K

Health Technology

| -1.65% | O: 0.02% H: 0.46% C: -0.14%
ABBV | News | $168.48 -0.63% 110K

Health Technology

| -3.12% | O: -0.83% H: 0.7% C: -0.27%
ABT | News | $106.84 -0.7% 5.5K

Health Technology

| -4.15% | O: -0.64% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.1K

Health Technology

| 0.99% | O: -0.86% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 490K

Health Technology

| 13.8% | O: -1.77% H: 0.46% C: 0.41%
AMGN | News | $273.54 0.6% 0.65% 8.5K

Health Technology

| -6.04% | O: -0.4% H: 1.6% C: 1.54%
report health treatment care global market

WAINUA™ (eplontersen) granted regulatory approval in the U.S. for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis
Published: 2023-12-21 (Crawled : 00:00) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 0

Health Technology

| 7.51% | O: 3.33% H: 0.0% C: -2.93%
IONS | $41.84 1.88% 1.86% 260

Health Technology

| -14.8% | O: 1.43% H: 3.87% C: 2.77%
AZN | News | $70.85 1.03% 1.02% 490K

Health Technology

| 6.86% | O: 1.06% H: 0.18% C: -1.06%
granted approval treatment

Acute Ischemic Stroke Diagnosis and Treatment Market to Reach $9.2 Billion, Globally, by 2032 at 6.1% CAGR: Allied Market Research
Published: 2023-12-14 (Crawled : 01:00) - prnewswire.com
FNCTF | News | $11.16 1.13% -20.84% 0

Communications

| -6.3% | O: -1.89% H: 0.0% C: 0.0%
AZNCF | News | $140.3 1.13% -4.19% 0

Health Technology

| 8.54% | O: 1.19% H: 3.09% C: 1.3%
SYK | $334.91 2.21% 0.33% 210

Health Technology

| 12.19% | O: 0.16% H: 0.52% C: -0.64%
MDT | $81.29 0.89% 0.26% 2.1K

Health Technology

| -0.74% | O: 1.05% H: 2.38% C: 0.81%
PHG | News | $21.01 1.94% -0.48% 0

Health Technology

| 0.24% | O: 4.96% H: 1.5% C: 0.91%
JNJ | News | $149.56 0.3% 0.03% 140K

Health Technology

| -2.66% | O: 1.81% H: 0.0% C: 0.0%
ABT | News | $106.84 -0.7% 5.5K

Health Technology

| 1.56% | O: 1.78% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 490K

Health Technology

| 7.51% | O: 1.21% H: 0.27% C: -0.52%
stroke reach treatment research market

Fortress Biotech Subsidiary Helocyte Announces Option Agreement with City of Hope for Exclusive Worldwide Rights to use a Novel Bispecific CMV/HIV CAR T Cell Therapy (optionally in combination with Triplex) for the Treatment of Adults Living with HIV-1
Published: 2023-10-16 (Crawled : 13:00) - globenewswire.com
AZNCF | News | $140.3 1.13% -4.19% 0

Health Technology

| 3.54% | O: -4.43% H: 3.6% C: 3.6%
FBIO | $1.81 13K

Health Technology

| -37.59% | O: 0.34% H: 4.12% C: -4.81%
AZN | News | $70.85 1.03% 1.02% 490K

Health Technology

| 5.23% | O: -1.07% H: 2.0% C: 1.82%
biotech worldwide hope cell treatment city agreement therapy living

Global Bronchial Spasms Treatment Market Set to Reach $505.07 Million by 2031 with a CAGR of 4.1%
Published: 2023-09-20 (Crawled : 22:00) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 0

Health Technology

| 2.9% | O: -1.13% H: 0.0% C: -0.63%
PFE | News 4 | $26.32 0.23% 0.15% 88K

Health Technology

| -21.71% | O: -0.45% H: 0.36% C: -1.85%
AZN | News | $70.85 1.03% 1.02% 490K

Health Technology

| 4.25% | O: 0.19% H: 0.03% C: -1.57%
reach treatment global set market

Minimal Residual Disease Testing Global Markets and Technology Research Report 2023-2028: Charting Cancer Treatment Trajectories - The Role of MRD Explored
Published: 2023-08-25 (Crawled : 14:30) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 0

Health Technology

| 3.16% | O: -3.27% H: 3.65% C: 3.36%
AZN | News | $70.85 1.03% 1.02% 490K

Health Technology

| 4.36% | O: 0.22% H: 0.6% C: 0.31%
AMGN | News | $273.54 0.6% 0.65% 8.5K

Health Technology

| 6.59% | O: 0.19% H: 0.25% C: -0.28%
disease report cancer treatment research global technology

Global Autoimmune Treatment Market Soars to $288.32 Billion by 2028, Driven by a 7.72% CAGR from 2023
Published: 2023-08-25 (Crawled : 02:00) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 0

Health Technology

| 3.16% | O: -3.27% H: 3.65% C: 3.36%
ALPMY | News | $9.49 -0.42% -1.11% 55K

Manufacturing

| -36.61% | O: -4.14% H: 5.37% C: 4.39%
NVS | News | $97.28 2.27% 1.47% 190K

Health Technology

| -1.96% | O: 0.67% H: 0.37% C: 0.26%
JNJ | News | $149.56 0.3% 0.03% 140K

Health Technology

| -8.75% | O: 0.51% H: 0.0% C: 0.0%
ABBV | News | $168.48 -0.63% 110K

Health Technology

| 15.2% | O: -0.11% H: 0.44% C: -0.22%
ABT | News | $106.84 -0.7% 5.5K

Health Technology

| 2.45% | O: -0.73% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 490K

Health Technology

| 4.36% | O: 0.22% H: 0.6% C: 0.31%
AMGN | News | $273.54 0.6% 0.65% 8.5K

Health Technology

| 6.59% | O: 0.19% H: 0.25% C: -0.28%
treatment global market

Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Report 2023: Increasing Prevalence of Lung Disease Drives Growth
Published: 2023-06-28 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 0

Health Technology

| 13.67% | O: 1.75% H: 0.06% C: 0.06%
AZNCF | News | $140.3 1.13% -4.19% 0

Health Technology

| -0.07% | O: 1.06% H: 0.72% C: 0.72%
ALPMY | News | $9.49 -0.42% -1.11% 55K

Manufacturing

| -37.44% | O: -1.98% H: 0.0% C: -0.47%
NVS | News | $97.28 2.27% 1.47% 190K

Health Technology

| 0.43% | O: 0.17% H: 0.85% C: 0.76%
GSK | News | $41.24 1.6% 0.0% 1.6K

Health Technology

| 16.07% | O: -1.21% H: 1.17% C: 0.91%
ABT | News | $106.84 -0.7% 5.5K

Health Technology

| -0.02% | O: -0.54% H: 0.78% C: 0.59%
SNY | News | $47.69 1.15% 1.13% 1.1K

Health Technology

| -12.8% | O: -1.86% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 490K

Health Technology

| -0.16% | O: -0.83% H: 0.89% C: 0.68%
lung disease report treatment global growth market

Genprex Receives U.S. FDA Fast Track Designation for REQORSA® Immunogene Therapy in Combination with Tecentriq® for the Treatment of Small Cell Lung Cancer
Published: 2023-06-28 (Crawled : 14:00) - biospace.com/
AZNCF | News | $140.3 1.13% -4.19% 0

Health Technology

| -1.72% | O: 0.74% H: 0.0% C: -2.36%
GNPX | $2.31 6.8% 6.77% 0

Health Technology

| 212.12% | O: 14.85% H: 1.18% C: -7.27%
AZN | News | $70.85 1.03% 1.02% 490K

Health Technology

| -1.14% | O: -0.29% H: 0.13% C: -0.7%
reqorsa fda lung cancer cell treatment designation therapy fast track designation

Global Glioblastoma Multiforme (GBM) Treatment Market Report 2023: Increasing Prevalence of Brain Disorders is Expected to Propel Growth
Published: 2023-05-17 (Crawled : 01:00) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 0

Health Technology

| -7.21% | O: -1.32% H: 0.92% C: -1.34%
NVS | News | $97.28 2.27% 1.47% 190K

Health Technology

| -3.84% | O: -0.51% H: 0.0% C: -1.05%
FUSN | $21.42 0.47% 0.47% 8

Health Technology

| 369.74% | O: -1.54% H: 1.34% C: -2.67%
DFFN 4 | $6.6 11.68% -34.32% 350K

Health Technology

| 14.59% | O: -0.25% H: 0.0% C: -0.78%
AZN | News | $70.85 1.03% 1.02% 490K

Health Technology

| -5.88% | O: 0.07% H: 0.03% C: -0.84%
AMGN | News | $273.54 0.6% 0.65% 8.5K

Health Technology

| 20.04% | O: -0.82% H: 0.03% C: -0.44%
propel report expected treatment global growth glioblastoma market

Artelo Biosciences Initiates the Phase 2a Portion of its CAReS Trial EvaluatingART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss
Published: 2023-04-25 (Crawled : 13:00) - biospace.com/
AZNCF | News | $140.3 1.13% -4.19% 0

Health Technology

| -8.36% | O: -2.02% H: 0.67% C: 0.67%
AZN | News | $70.85 1.03% 1.02% 490K

Health Technology

| -6.54% | O: 0.91% H: 0.08% C: -1.1%
ARTL | News | $1.31 0.74% 1.87% 26

Health Technology

| -51.3% | O: 0.0% H: 0.0% C: -21.75%
art27 treatment cares trial

GRAIL Presents New Data Demonstrating That Methylation Assay Detects Residual Hematologic Cancer After Treatment at American Association for Cancer Research (AACR) Annual Meeting 2023
Published: 2023-04-17 (Crawled : 23:00) - biospace.com/
ILMN | $124.46 3.5% 3.34% 3.5K

Health Technology

| -45.41% | O: 0.45% H: 0.5% C: 0.41%
AZN | News | $70.85 1.03% 1.02% 490K

Health Technology

| -4.08% | O: -0.14% H: 0.08% C: -0.18%
association cancer treatment research meeting

The Glioblastoma Multiforme (GBM) Treatment Market Overview: Market Size, Expected CAGR, Growth Driver And Major Players
Published: 2023-04-13 (Crawled : 10:00) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 0

Health Technology

| -4.72% | O: 0.0% H: 1.63% C: 1.63%
NVSEF | News | $96.0 0.94% 6.88% 0

Health Technology

| 19.63% | O: 1.25% H: 0.51% C: 0.51%
NVS | News | $97.28 2.27% 1.47% 190K

Health Technology

| 2.48% | O: 1.3% H: 0.56% C: 0.51%
AZN | News | $70.85 1.03% 1.02% 490K

Health Technology

| -3.95% | O: 0.39% H: 1.05% C: 0.97%
AMGN | News | $273.54 0.6% 0.65% 8.5K

Health Technology

| 9.64% | O: -0.36% H: 1.33% C: 1.14%
expected treatment growth glioblastoma market

Artelo Biosciences Completes Enrollment of the Phase 1b Stage of its CAReS Clinical Trial Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight LossExpects to Commence Phase 2a of CAReS During the First Quarter of 2023
Published: 2023-02-02 (Crawled : 15:20) - biospace.com/
AZNCF | News | $140.3 1.13% -4.19% 0

Health Technology

| 9.78% | O: -2.3% H: 2.11% C: 1.78%
AZN | News | $70.85 1.03% 1.02% 490K

Health Technology

| 11.47% | O: -0.31% H: 0.05% C: -0.33%
ARTL | News | $1.31 0.74% 1.87% 26

Health Technology

| -58.41% | O: -1.27% H: 1.67% C: -0.96%
art27 treatment cares trial art27.13 phase 2b

Artelo Biosciences Completes Enrollment of the Phase 1b Stage of its CAReS Clinical Trial Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss
Published: 2023-02-02 (Crawled : 14:20) - globenewswire.com
AZNCF | News | $140.3 1.13% -4.19% 0

Health Technology

| 9.78% | O: -2.3% H: 2.11% C: 1.78%
AZN | News | $70.85 1.03% 1.02% 490K

Health Technology

| 11.47% | O: -0.31% H: 0.05% C: -0.33%
ARTL | News | $1.31 0.74% 1.87% 26

Health Technology

| -58.41% | O: -1.27% H: 1.67% C: -0.96%
art27 treatment cares trial art27.13 phase 2b

The Worldwide Lysosomal Disease Treatment Industry is Expected to Reach $11 Billion by 2028
Published: 2023-01-13 (Crawled : 13:00) - prnewswire.com
SNYNF | News | $94.25 1.67% -2.18% 0

Health Technology

| -5.13% | O: -0.13% H: 0.76% C: 0.76%
AZNCF | News | $140.3 1.13% -4.19% 0

Health Technology

| 1.18% | O: 2.77% H: 0.63% C: 0.63%
TAK | News | $13.38 0.15% -0.67% 2.9K

Health Technology

| -15.22% | O: 0.13% H: 2.35% C: 2.16%
PFE | News 4 | $26.32 0.23% 0.15% 88K

Health Technology

| -44.83% | O: -0.44% H: 1.39% C: 0.74%
NVS | News | $97.28 2.27% 1.47% 190K

Health Technology

| 9.17% | O: 0.15% H: 0.65% C: 0.4%
JNJ | News | $149.56 0.3% 0.03% 140K

Health Technology

| -13.99% | O: -0.47% H: 0.47% C: 0.14%
LLY | News | $745.69 1.96% 0.04% 4K

Health Technology

| 105.79% | O: 0.13% H: 1.04% C: 0.57%
SNY | News | $47.69 1.15% 1.13% 1.1K

Health Technology

| -2.7% | O: 1.89% H: 0.0% C: 0.0%
BMRN | $92.06 2.87% 2.79% 97

Health Technology

| -18.94% | O: -1.16% H: 2.27% C: 0.42%
AZN | News | $70.85 1.03% 1.02% 490K

Health Technology

| 1.1% | O: 1.27% H: 0.78% C: 0.15%
treatment disease expected

Global Type 2 Diabetes Treatment Market Outlook Report 2022-2023 & 2027: Patent Cliff, Oral Antidiabetics, and Growing Focus on Accessibility and Affordability of Medicine Bolsters Growth
Published: 2023-01-04 (Crawled : 23:00) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 0

Health Technology

| 1.64% | O: -0.93% H: 3.08% C: 3.08%
NVO | News | $128.64 2.7% -1.37% 60K

Health Technology

| -5.94% | O: -0.89% H: 1.18% C: 0.52%
NVS | News | $97.28 2.27% 1.47% 190K

Health Technology

| 7.64% | O: -0.85% H: 0.2% C: -0.29%
JNJ | News | $149.56 0.3% 0.03% 140K

Health Technology

| -16.92% | O: -0.62% H: 0.54% C: -0.12%
SNY | News | $47.69 1.15% 1.13% 1.1K

Health Technology

| -4.45% | O: -3.07% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 490K

Health Technology

| 1.94% | O: -0.49% H: 1.65% C: 0.94%
treatment patent global report growing diabetes growth market

Peripheral neuropathy treatment market size to increase by USD 372.56 million: North America to contribute 33% of market growth - Technavio
Published: 2022-12-15 (Crawled : 03:00) - prnewswire.com
ENDPQ | News | $0.0007 -50.0% 1K

n/a

| -95.15% | O: -3.03% H: 3.38% C: -7.75%
AZNCF | News | $140.3 1.13% -4.19% 0

Health Technology

| 0.39% | O: 0.14% H: 0.4% C: -1.41%
VTRS | News A | $11.36 0.98% 0.97% 210

Health Technology

| 0.35% | O: -0.53% H: 0.71% C: -1.07%
NVS | News | $97.28 2.27% 1.47% 190K

Health Technology

| 6.84% | O: -0.71% H: 0.08% C: -1.07%
AZN | News | $70.85 1.03% 1.02% 490K

Health Technology

| 0.58% | O: -0.58% H: 0.11% C: -0.41%
america treatment growth market

← Previous
1
2
3
Next →

tags : Treatment entities : Astrazeneca plc

save search

Gainers vs Losers

Top 10 Gainers

Your saved searches

tags : Treatment entities : Astrazeneca plc save search

Gainers vs Losers

Top 10 Gainers

Your saved searches

tags : Treatment entities : Astrazeneca plc

save search